- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01969305
Youth Drug Abuse Prevention in Kazakhstan
A Computerized Family-Based Youth HIV and Drug Abuse Prevention in Kazakhstan
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to adapt an evidence-based HIV and substance use prevention intervention for most at-risk adolescents and their caregivers (parents or other adult family members) from drug-risk communities in Kazakhstan. Located on major drug trafficking routes (between Afghanistan, the world's largest opium producer, and Russia), Central Asia and Kazakhstan, in particular, face one of the fastest growing rates of HIV infection in the world disproportionately affecting young people ages 15-29. Youth exposed to drugs at home and in the community are particularly at risk.
The country's HIV prevention efforts for youth are limited to a knowledge-based approach, which does not equip at-risk youth with skills required to deal with situations of risk exposure. Parents or other caregivers, who represent a significant protective force in a family-oriented culture of Central Asia, are largely excluded from youth prevention efforts in Kazakhstan.
KFT is a family-based multi-media intervention designed to reduce sexual and drug-related risks for HIV infection among at-risk adolescents. To address the dual risk of HIV and substance use, the proposed intervention combines empirically tested skills-based and family involvement approaches and utilizes multi-media computer technology to develop an engaging and potentially cost-effective tool with high fidelity and easy scalability. During each of the sessions, youth and caregivers will participate in interactive computer activities to learn skills and have conversations focused on risky behaviors.
During the development stage, the US and Kazakhstani investigative team will conduct formative research and will work closely with the local Community Collaborative Board to adapt the intervention to the cultural context of at-risk families in Kazakhstan.
Further, the KFT intervention will be tested in a pilot Randomized Controlled Trial with 248 adolescents and 248 of their caregivers. Intervention arm adolescent-caregiver pairs will receive three 45-minute interactive multi-media sessions with avatars customized to participants' gender that will focus on risk reduction self-efficacy, resistance to peer pressure, and caregiver-adolescent communication, support and monitoring. Adolescents from both intervention and control arms will receive the usual care services available for at-risk youth, which includes health education sessions on HIV and drug use delivered by peer educators and outreach workers.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Almaty, Kazakhstan
- Columbia University Global Heath Research Center of Central Asia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Youth are between the ages of 14-17.
- Youth exhibits one of the following risk factors: substance-using peers or friends, parental history of drug use, parental history of alcohol problems, parental criminal history, adolescent's history of drug use, running away from home, school drop-out or history of sexual activity.
- You and caregiver are able to speak and read Russian.
- Both youth and caregiver (parent or other caregiving adult family member) can commit to study participation.
- Youth and caregiver do not plan to move in the next 6 months.
Exclusion Criteria:
- Youth are under the age of 14 or over the age of 17.
- Youth does not exhibit one of the aforementioned risk factors.
- Youth and caregiver do not speak and read Russian.
- Youth and caregiver are unable to commit to study participation.
- Youth or caregiver has plans to move within the next 6 months.
- Youth or caregiver has a cognitive impairment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Kazakhstani Family Together (KFT)
Usual Care Plus KFT: Family-based multi-media HIV and drug abuse prevention intervention
|
Adolescent-caregiver pairs will receive three 45-minute interactive multi-media sessions with avatars customized to participants' gender that will focus on risk reduction self-efficacy, resistance to peer pressure, decision-making skills and caregiver-adolescent communication, support and monitoring to strengthen youth's relationships with caregivers and reduce youth's risks of drug use and sexual risk behaviors.
Through the multimedia tool, participants will confront a series of sexual risks and substance use related situations and will practice their listening, empathy, assertiveness, refusal, and other interpersonal skills.
Each caregiver-youth pair will work jointly and engage in discussions, exercises, and behavioral rehearsal as directed by the program.
|
|
Experimental: Health education curriculum
Usual Care Alone: Health education curriculum on HIV and drug use prevention
|
Adolescents from both study arms will receive the usual care, a health education program about how to prevent drug use and HIV/STIs (sexually transmitted infections). The health education curriculum is delivered in a group format by trained peer educators and outreach workers. The curriculum consists of three 45-minute sessions that include lectures and interactive quizzes about drugs and HIV. These three sessions include information on the following topics:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in onset and 30-day alcohol and drug use from baseline to 6 months
Time Frame: Up to 6-months
|
Measures will ask youth to report the frequency and quantity of alcohol and drug use in the past 30 days (number of alcoholic drinks, puffs of marijuana, or initiation of injection drug use).
Substance use includes specific probes, including street names for alcohol, marijuana, ecstasy, cocaine, injecting drug use, heroin, inhalants, hallucinogens, and other drugs as appropriate to the context.
|
Up to 6-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in onset and sexual risk behaviors from baseline to 6 months
Time Frame: Up to 6-months
|
Measures will ask youth to report a history of sexual intercourse and the age of onset, proportion of unprotected acts in past 30 days, frequency of condom use in past 30 days, condom use during the last episode, and number of sexual partners in past 30 days.
|
Up to 6-months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Leyla Ismayilova, PhD, University of Chicago School of Social Service Administration
Publications and helpful links
General Publications
- Ismayilova L, Terlikbayeva A. Building Competencies to Prevent Youth Substance Use in Kazakhstan: Mixed Methods Findings From a Pilot Family-Focused Multimedia Trial. J Adolesc Health. 2018 Sep;63(3):301-312. doi: 10.1016/j.jadohealth.2018.04.005. Epub 2018 Jul 10.
- Ismayilova L, Terlikbayeva A, Rozental Y. Computerized intervention to prevent drug use among at-risk adolescents in Central Asia: Preliminary family-level findings from a pilot mixed methods trial. Int J Drug Policy. 2019 Jun;68:75-85. doi: 10.1016/j.drugpo.2019.03.022. Epub 2019 Apr 16.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB13-0841
- R34DA033201 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug Use
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)Active, not recruitingPolysubstance Drug Use (Indiscriminate Drug Use)United States
-
University of California, Los AngelesInstituto Nacional de Psiquiatría Dr. Ramón de la FuenteCompletedDrug Use | Harmful Use
-
University of California, Los AngelesCompleted
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA); Medical University of South Carolina; University of ArkansasActive, not recruitingDrug UseUnited States
-
Hamad Medical CorporationPrimary Health Care Corporation, QatarActive, not recruiting
-
PT. Kimia Farma (Persero) TbkPT Pharma Metric LabsCompleted
-
PT BernofarmPT Pharma Metric LabsCompleted
-
Ain Shams UniversityRecruiting
-
PT Kalbe Farma TbkPT Pharma Metric LabsCompleted
-
Assistance Publique Hopitaux De MarseilleUnknown
Clinical Trials on Kazakhstani Family Together
-
MetroHealth Medical CenterThe Cleveland Music School Settlement; Kulas FoundationTerminated
-
York UniversityMcMaster University; University of TorontoCompletedFamily Conflict | Internet-Based InterventionCanada
-
York UniversityUniversity of TorontoNot yet recruitingYoung Adults | Interpersonal Relations | Parent Child RelationshipCanada
-
Dana-Farber Cancer InstituteRecruitingInsomnia | Survivorship | Insomnia ChronicUnited States
-
University of ConnecticutNational Heart, Lung, and Blood Institute (NHLBI); Worcester Polytechnic InstituteCompleted
-
York UniversityMcMaster University; University of TorontoActive, not recruitingMarital Relationship | Family Conflict | Internet-Based Intervention | Interparental Conflict | Marital ConflictCanada
-
Centre hospitalier de Ville-Evrard, FranceRecruitingSchizophrenia | Bipolar Disorder | Major Depressive Disorder | Severe Mental IllnessFrance
-
University of British ColumbiaPublic Health Agency of Canada (PHAC); The Bridge Youth and Family Services...CompletedOverweight and Obesity | Health Knowledge, Attitudes, PracticeCanada
-
Caroline RowlandCompletedLanguage DevelopmentUnited Kingdom
-
Michigan State UniversityUniversity of Michigan; Wake Forest University Health Sciences; Babes-Bolyai...CompletedUsual Care | Telemedicine: Smoking Cessation App Only | Telemedicine: Smoking Cessation Counseling | Telemedicine: App + CounselingRomania